These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35040414)
1. Cytokines Involved in COVID-19 Patients with Diabetes: A Systematic Review. George TP; Joy SS; Rafiullah M; Siddiqui K Curr Diabetes Rev; 2023; 19(3):e180122200321. PubMed ID: 35040414 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature. Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. Yin T; Li Y; Ying Y; Luo Z BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Bajgain KT; Badal S; Bajgain BB; Santana MJ Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414 [TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716 [TBL] [Abstract][Full Text] [Related]
6. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S mBio; 2021 Feb; 12(1):. PubMed ID: 33563817 [TBL] [Abstract][Full Text] [Related]
7. An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19. Argano C; Mallaci Bocchio R; Lo Monaco M; Scibetta S; Natoli G; Cavezzi A; Troiani E; Corrao S Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270015 [TBL] [Abstract][Full Text] [Related]
8. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology. Suárez-Reyes A; Villegas-Valverde CA MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614 [TBL] [Abstract][Full Text] [Related]
9. Diabetes in the COVID-19 pandemic era. Bonansea TCP; Santos LPD; Zintl K; Souza ACDS Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303 [TBL] [Abstract][Full Text] [Related]
10. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients. Subbaram K; Ali PSS; Ali S Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090 [TBL] [Abstract][Full Text] [Related]
11. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Quirch M; Lee J; Rehman S J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537 [TBL] [Abstract][Full Text] [Related]
12. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Das S; K R A; Birangal SR; Nikam AN; Pandey A; Mutalik S; Joseph A Life Sci; 2020 Oct; 258():118202. PubMed ID: 32758625 [TBL] [Abstract][Full Text] [Related]
13. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Johnson BS; Laloraya M Cytokine Growth Factor Rev; 2020 Aug; 54():32-42. PubMed ID: 32747157 [TBL] [Abstract][Full Text] [Related]
14. Hyperinflammatory Response in COVID-19: A Systematic Review. Silva MJA; Ribeiro LR; Gouveia MIM; Marcelino BDR; Santos CSD; Lima KVB; Lima LNGC Viruses; 2023 Feb; 15(2):. PubMed ID: 36851766 [TBL] [Abstract][Full Text] [Related]
15. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical). Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817 [TBL] [Abstract][Full Text] [Related]
16. Features of severe COVID-19: A systematic review and meta-analysis. Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457 [TBL] [Abstract][Full Text] [Related]
17. Probable Neuropsychological and Cognitive Complications Due to Cytokine Storm in Patients With COVID-19. Keshtgar Z; Chalabianloo G; Esmaeili N Basic Clin Neurosci; 2023; 14(5):549-564. PubMed ID: 38628831 [TBL] [Abstract][Full Text] [Related]
18. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging". Meftahi GH; Jangravi Z; Sahraei H; Bahari Z Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477 [TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
20. An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients. Srivastava A; Rockman-Greenberg C; Sareen N; Lionetti V; Dhingra S Mol Cell Biochem; 2022 Jun; 477(6):1681-1695. PubMed ID: 35235124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]